Abstract
Motivated by the desire to assess nonpharmaceutical interventions for pandemic influenza, we seek in this study to quantify the routes of transmission for this disease. We construct a mathematical model of aerosol (i.e., droplet-nuclei) and contact transmission of influenza within a household containing one infected. An analysis of this model in conjunction with influenza and rhinovirus data suggests that aerosol transmission is far more dominant than contact transmission for influenza. We also consider a separate model of a close expiratory event, and find that a close cough is unlikely (≈1% probability) to generate traditional droplet transmission (i.e., direct deposition on the mucous membranes), although a close, unprotected and horizontally-directed sneeze is potent enough to cause droplet transmission. There are insufficient data on the frequency of close expiratory events to assess the relative importance of aerosol transmission and droplet transmission, and it is prudent to leave open the possibility that droplet transmission is important until proven otherwise. However, the rarity of close, unprotected and horizontally-directed sneezes—coupled with the evidence of significant aerosol and contact transmission for rhinovirus and our comparison of hazard rates for rhinovirus and influenza—leads us to suspect that aerosol transmission is the dominant mode of transmission for influenza.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alford, R.H., Kasel, J.A., Gerone, P.J., Knight, V., 1966. Human influenza resulting from aerosol inhalation. Proc. Soc. Exp. Biol. Med. 122, 800–804.
Ansari, S.A., Springthorpe, V.S., Sattar, S.A., Rivard, S., Rahman, M., 1991. Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J. Clin. Mircobiol. 29, 2115–2119.
Ball, F., Neal, P., 2002. A general model for stochastic SIR epidemics with two levels of mixing. Math. Biosci. 180, 73–102.
Barry, J.M., 2004. The Great Influenza. Penguin Books, London.
Bean, B., Moore, B.M., Sterner, B., Peterson, L.R., Gerding, D.N., Balfour, H.H. Jr., 1982. Survival of influenza virus on environmental surfaces. J. Infect. Dis. 146, 47–51.
Bridges, C.B., Kuehnert, M.J., Hall, C.B., 2003. Transmission of influenza: implications for control in health care settings. Clin. Infect. Dis. 37, 1094–1101.
Bynoe, M.L., Hobson, D., Horner, J., Kipps, A., Schild, G.C., Tyrrell, D.A.J., 1961. Inoculation of human volunteers with a strain of virus isolated from a common cold. Lancet 1, 1194–1196.
Calfee, D.P., Peng, A.W., Hussey, E.K., Lobo, M., Hayden, F.G., 1999. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection. Antivir. Ther. 4, 143–149.
Carrat, F., Sahler, C., Rogez, S., Leruez-Ville, M., Freymuth, F., Le Gales, C., Bungener, M., Houseet, B., Nicolas, M., Rouzioux, C., 2002. Influenza burden of illness. Arch. Intern. Med. 162, 1842–1848.
Cate, T.R., Couch, R.B., Johnson, K.M., 1964. Studies with rhinoviruses in volunteers: production of illness, effect of naturally acquired antibody, and demonstration of a protective effect not associated with serum antibody. J. Clin. Investig. 43, 56–67.
Cauchemez, S., Carrat, F., Viboud, C., Valleron, A.J., Boelle, P.Y., 2004. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat. Med. 23, 3469–3487.
Committee on the Development of Reusable Facemasks for Use During an Influenza Pandemic, Institute of Medicine, 2006. Reusability of Facemasks During an Influenza Pandemic. National Academies Press, Washington.
Connor, R.J., Kawaoka, Y., Webster, R.G., Paulson, J.C., 1994. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 203, 17–23.
Couch, R.B., Gerone, P.J., Cate, T.R., Griffith, W.R., Alling, D.W., Knight, V., 1965. Preparation and properties of a small-particle aerosol of coxsackie A21. Proc. Soc. Exp. Biol. Med. 118, 818.
Couch, R.B., Cate, T.R., Douglas, R.G. Jr., Gerone, P.J., Knight, V., 1966. Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol. Rev. 30, 517–529.
Couch, R.B., Douglas, R.G. Jr., Fedson, D.S., Kasel, J.A., 1971. Correlated studies of a recombinant influenza-virus vaccine. III. Protection against experimental influenza in man. J. Infect. Dis. 124, 473–480.
Couch, R.B., Kasel, J.A., Gerin, J.A., Schulman, J.L., Kilbourne, E.D., 1974. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J. Infect. Dis. 129, 411–420.
D’Alessio, D.J., Peterson, J.A., Dick, C.R., Dick, E.C., 1976. Transmission of experimental rhinovirus colds in volunteer married couples. J. Infect. Dis. 133, 28–36.
D’Alessio, D.J., Meschievitz, C.K., Peterson, J.A., Dick, C.R., Dick, E.C., 1984. Short-duration exposure and the transmission of rhinoviral colds. J. Infect. Dis. 150, 189–194.
de Jong, M.D., Tran, T.T., Truong, H.K., Vo, M.H., Smith, G.J., Chau, N.V., Van Cam, B., Qui, P.T., Ha, D.Q., Guan, Y., Peiris, J.S.M., Hien, T.T., Farrar, J., 2005. Oseltamivir resistance during treatment of infleunza A (H5N1) infection. N. Engl. J. Med. 353, 2667–2672.
Dick, E.C., Jennings, L.C., Mink, K.A., Wartgow, C.D., Inhorn, S.L., 1987. Aerosol transmission of rhinovirus colds. J. Infect. Dis. 156, 442–448.
Douglas, R.G., 1970. Pathogenesis of rhinovirus common colds in human volunteers. Ann. Otol. Rhinol. Laryngol. 79, 563–571.
Douglas, R.G. Jr., 1975. Influenza in man. In: Kilbourne, E.D. (Ed.), The Influenza Viruses and Influenza, pp. 395–447. Academic Press, New York.
Douglas, R.G. Jr., Cate, T.R., Gerone, P.J., Couch, R.B., 1966. Quantitative rhinovirus shedding patterns in volunteers. Am. Rev. Respir. Dis. 94, 159–167.
Duguid, J.P., 1946. The size and duration of air-carriage of respiratory droplets and aerosol. J. Hyg. 4, 471–480.
Ferguson, N., Cummings, D.A.T., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S., Burke, D.S., 2005. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437, 209–214.
Fox, J.P., Kilbourne, E.D., 1973. From the National Institutes of Health: epidemiology of influenza—summary of influenza workshop IV. J. Infect. Dis. 128, 361–386.
Fox, J.P., Cooney, M.K., Hall, C.E., 1975. The Seattle virus watch. Am. J. Epidemiol. 101, 122–143.
Fox, J.P., Cooney, M.K., Hall, C.E., Foy, H.M., 1985. Rhinoviruses in Seattle families, 1975–1979. Am. J. Epidemiol. 122, 830–846.
Fraser, C., Riley, S., Anderson, R.M., Ferguson, N.M., 2004. Factors that make an infectious disease outbreak controllable. PNAS 101, 6146–6151.
Gerone, P.J., Couch, R.B., Keefer, G.V., Douglas, R.G., Derrenbacker, E.B., Knight, V., 1966. Assessment of experimental and natural viral aerosols. Bact. Rev. 30, 576.
Gwaltney, J.M. Jr., Moskalski, P.B., Hendley, J.O., 1978. Hand-to-hand transmission of rhinovirus colds. Ann. Intern. Med. 88, 463–467.
Hall, C.B., Douglas, R.G. Jr., Geiman, J.M., Meagher, M.P., 1979. Viral shedding patterns of children with influenza B infection. J. Infect. Dis. 140, 610–613.
Harper, G.J., 1961. Airborne micro-organisms: survival tests with four viruses. J. Hyg. (Camb.) 59, 479–486.
Hayden, F.G., Treanor, J.J., Betts, R.F., Lobo, M., Esinhart, J.D., Hussey, E.K., 1996. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 275, 295–299.
Hayden, F.G., Fritz, R.S., Lobo, M.C., Alvord, W.G., Strober, W., Straus, S.E., 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. J. Clin. Inv. 101, 643–649.
Hayden, F.G., Gubareva, L.V., Monto, A.S., Klein, T.C., Elliott, M.J., Hammond, J.M., Sharp, S.J., Ossi, M.J., 2000. Inhaled zanamivir for the prevention of influenza in families. NEJM 343, 1282–1289.
Health and Human Services Department, U.S. Government, 2004. HHS Pandemic Influenza Plan. Health and Human Services Department, Washington.
Heinsohn, R.J., Cimbala, J.M., 1999. Indoor Air Quality Engineering. Dekker, New York.
Hemmes, J.H., Winkler, K.C., Kool, S.M., 1960. Virus survival as a seasonal factor in influenza and poliomyelitis. Nature 188, 430–431.
Hendley, J.O., Wenzel, R.P., Gwaltney, J.M. Jr., 1973. Transmission of rhinovirus colds by self-inoculation. NEJM 288, 1361–1364.
Hendley, J.O., Gwaltney, J.M. Jr., 1988. Mechanisms of transmission of rhinovirus infections. Epidemiol. Rev. 10, 242–258.
Hers, J.F.P., Mulder, J., 1961. Broad aspects of the pathology and pathogenesis of human influenza. Am. Rev. Resp. Dis. 83, 84–89.
Hinds, W.C., 1982. Aerosol Technology. Wiley, New York.
Homeland Security Council, 2006. National Strategy for Pandemic Influenza: Implementation Plan. The White House, Washington.
International Commission on Radiological Protection (ICRP), 1994. ICRP Publication 66: Human respiratory tract model for radiological protection. Ann. ICRP 24, 36–54 and 231–299 (Pergamon Press, New York).
Jennings, L.C., Dick, E.C., 1987. Transmission and control of rhinovirus colds. Eur. J. Epidemiol. 3, 327–335.
Kaiser, L., Henry, D., Flack, N.P., Keene, O., Hayden, F.G., 2000. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study. Clin. Infect. Dis. 30, 587–589.
Karim, Y.G., Ijaz, M.K., Sattar, S.A., Johnson-Lussenburg, C.M., 1985. Effect of relative humidity on the airborne survival of rhinovirus-14. Can. J. Microbiol. 31, 1058–1061.
Khan, T.A., Higuchi, H., Marr, D.R., Glauser, M.N., 2004. Unsteady flow measurements of human microenvironment using time resolved particle image velocimetry. RoomVent 2004, Coimbra, Portugal, September 5–8, 2004.
Knight, V., 1973. Airborne transmission and pulmonary deposition of respiratory viruses. In: Knight, V. (Ed.), Viral and Mycoplasmal Infections of the Respiratory Tract, pp. 1–9. Lea & Febiger, Philadelphia.
Knight, V., Fedson, D., Baldini, J., Douglas, R.G. Jr., Couch, R.B., 1970. Amantadine therapy of epidemic influenza A2 (Hong Kong). Infect. Immun. 1, 200–204.
Le, Q.M., Kiso, M., Someya, K., Sakai, Y.T., Nguyen, T.H., Nguyen, K.H.L., Pham, N.D., Ngyen, H.H., Yamada, S., Muramoto, Y., Horimoto, T., Takada, A., Goto, H., Suzuki, T., Suzuki, Y., Kawaoka, Y., 2005. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437, 1108.
Leadbetter, M.R., Lindgren, G., Holger, R., 1980. Extremes and Related Properties of Random Sequences and Processes. Springer, New York.
Lloyd-Smith, J.O., Schreiber, S.J., Kopp, P.E., Getz, W.M., 2005. Superspreading and the impact of individual variation on disease emergence. Nature 438, 355–359.
Longini, I.M. Jr., Koopman, J.S., 1982. Household and community transmission parameters from final distributions of infections in households. Biometrics 38, 115–126.
Loosli, C.G., Lemon, H.M., Robertson, O.H., Appel, E., 1943. Experimental air-borne influenza infection. I. Influence of humidity on survival of virus in air. Proc. Soc. Exp. Biol. 53, 205–206.
Loudon, R.G., Brown, L.C., 1967. Cough frequency in patients with respiratory disease. Am. Rev. Resp. Dis. 96, 1137–1143.
Loudon, R.G., Roberts, R.M., 1967. Droplet expulsion from the respiratory tract. Am. Rev. Resp. Dis. 95, 435–442.
Markel, H., Stern, A.M., Navarro, J.A., Michalsen, J.R., 2006. A historical assessment of nonpharmaceutical disease containment strategies employed by selected U.S. communities during the second wave of the 1918–1920 influenza pandemic. Defense Threat Reduction Agency, Fort Belvoir, VA, http://www.dtra.mil/asco/DTRAFinalInfluenzaReport.pdf.
McLean, R.L., 1961. General discussion: the mechanism of spread of Asian influenza. Am. Rev. Respir. Dis. 83, 36–38.
Meschievitz, C.K., Schultz, S.B., Dick, E.C., 1984. A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. J. Infect. Dis. 150, 195–201.
Miller, S.L., Nazaroff, W.W., 2001. Environmental tobacco smoke particles in multizone indoor environments. Atmos. Environ. 35, 2053–2067.
Morens, D.M., Rash, V.M., 1995. Lessons from a nursing home outbreak of influenza A. Infect. Control Hosp. Epidemiol. 16, 275–280.
Moser, M.R., Bender, T.R., Margolis, H.S., Noble, G.R., Kendal, A.P., Ritter, D.G., 1979. An outbreak of influenza aboard a commercial airliner. Am. J. Epidemiol. 110, 1–6.
Nicas, M., Sun, G., 2006. An integrated model of infection risk in a health-care environment. Risk Anal. 26, 1085–1096.
Nicas, M., Nazaroff, W.W., Hubbard, A., 2005. Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J. Occup. Environ. Hyg. 2, 143–154.
Niinimaa, V., Cole, P., Mintz, S., Shephard, R.J., 1980. The switching point from nasal to oronasal breathing. Respir. Physiol. 42, 61–71.
Papineni, R.S., Rosenthal, F.S., 1997. The size distribution of droplets in the exhaled breath of healthy subjects. J. Aer. Med. 10, 105–116.
Phelps, E.B., 1942. The state of suspension of bacteria in the air as measured by settling rates. In: Aerobiology, AAAS, Publication No. 17, pp. 133–137. Washington.
Rampey, A.H. Jr., Longini, I.M. Jr., Haber, M., Monto, A.S., 1992. A discrete-time model for the statistical analysis of infectious disease incidence data. Biometrics 48, 117–128.
Reed, S.E., 1975. An investigation of the possible transmission of rhinovirus colds through indirect contact. J. Hyg. (Camb.) 75, 249–258.
Rogers, G.N., D’Souza, B.L., 1989. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 173, 317–322.
Rudnick, S.N., Milton, D.K., 2003. Risk of indoor airborne infection transmission estimated from carbon dioxide concentration. Indoor Air 13, 237–245.
Ryan, M.A.K., Christian, R.S., Wohlrabe, J., 2001. Handwashing and respiratory illness among young adults in military training. Am. J. Prev. Med. 21, 79–83.
Schaffer, F.L., Soergel, M.E., Straube, D.C., 1976. Survival of airborne influenza virus: effects of propogating host, relative humidity, and composition of spray fluids. Arch. Virol. 51, 263–273.
Sherman, M.H., Matson, N., 1997. Residential ventilation and energy characteristics. ASHRAE Trans. 103, 717–730.
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., Kawaoka, Y., 2006. Avian flu: influenza virus receptors in the human airway. Nature 440, 435–436.
Tannock, G.A., Gillett, S.M., Gillett, R.S., Barry, R.D., Hensley, M.J., Herd, R., Reid, A.L.A., Saunders, N.A., 1988. A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers. Epidem. Infect. 101, 611–621.
Tellier, R., 2006. Review of aerosol transmission of influenza A virus. Emerg. Infect. Dis. 12, 1657–1662.
Tumpey, T.M., Basler, C.F., Aguilar, P.V., Zeng, H., Solorzano, A., Swayne, D., Cox, N.J., Katz, J.M., Taubenberger, J.K., Palese, P., Garcia-Sastre, A., 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77–80.
Wallace, L., 1996. Indoor particles: a review. Air Waste Manag. Assoc. 46, 98–126.
Wein, L.M., Atkinson, M.P., 2006. Assessing Infection Control Measures for Pandemic Influenza. Graduate School of Business, Stanford University, Stanford.
Wells, W.F., 1955. Airborne Contagion and Hygiene. Harvard University Press, Cambridge.
Winkler, K.C., 1973. In: Hers, J.F.P., Winkler, K.C. (Eds.), Aerosol Transmission and Airborne Infection. Wiley, New York.
Winther, B., Gwaltney, J.M. Jr., Mygind, N., Turner, R.B., Hendley, J.O., 1986. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 256, 1763–1767.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atkinson, M.P., Wein, L.M. Quantifying the Routes of Transmission for Pandemic Influenza. Bull. Math. Biol. 70, 820–867 (2008). https://doi.org/10.1007/s11538-007-9281-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-007-9281-2